Organization
Charité – Universitätsmedizin Berlin, Department of Rheumatology and Clinical Immunology, Berlin, Germany
3 abstracts
Abstract
ANTI-MODIFIED PROTEIN AUTOANTIBODIES IN RA DISPLAY IMPORTANT PEPTIDE CROSS-REACTIVITY BUT YET PROTEIN RECOGNITION SELECTIVITYOrg: Karolinska Institute, Department of Medicine, Stockholm, Sweden, Charité – Universitätsmedizin Berlin, Department of Rheumatology and Clinical Immunology, Berlin, Germany, KTH Royal Institute of Technology, School of Biotechnology, Stockholm, Sweden, University of Minnesota, The Center for Immunology, Minneapolis, United States of America, Engine GmbH, Engine GmbH, Hennigsdorf, Germany,
Abstract
AN UPDATE ON THE INTEGRATED SAFETY ANALYSIS OF FILGOTINIB IN PATIENTS WITH MODERATE TO SEVERE ACTIVE RHEUMATOID ARTHRITIS OVER A MEDIAN OF 4.3 YEARSOrg: Oregon Health and Science University, School of Medicine, Portland, United States of America, Medical University of Vienna, Department of Medicine III, Division of Rheumatology, Vienna, Austria, University of Milan, Department of Clinical Sciences and Community Health, Milan, Italy, ASST Gaetano Pini-CTO, Department of Rheumatology and Medical Sciences, Milan, Italy, University of Occupational and Environmental Health, Department of Internal Medicine, Kitakyushu, Japan,
Abstract
ALTERED IMMUNOLOGICAL CIRCADIAN RHYTHMS AND THE EFFECT OF TREATMENT WITH GLUCOCORTICOIDS ON CIRCADIAN RHYTHMS OF IMMUNE CELLS IN PATIENTS WITH RHEUMATOID ARTHRITIS: BRING BACK THE RHYTHMOrg: Charité – Universitätsmedizin Berlin, Department of Rheumatology and Clinical Immunology, Berlin, Germany, Deutsches Rheuma-Forschungszentrum Berlin (DRFZ), ein Institut der Leibniz-Gemeinschaft, Glucocorticoid and Bioenergetic, Berlin, Germany,